Europe#s innovation potential is currently dominated by well-established large companies. In most member countries the bulk of R&D expenditures is spend by large companies. Following OECD data, SME's share in total R&D spending amount to 8% in Germany or Japan, around 15% in US, France, Korea or...

The importance and contribution of new technology-based Firms (NTBFs) to long term economic development is at the center of a controversial debate. This paper provides an overview of the current status of research on various issues concerning NTBFs in Germany. The issues covered include the...

Der vorliegende Bericht stellt die Ergebnisse der Evaluation der BMBF-Fördermaßnahmen BioChance und BioChancePlus dar. Beide zielten als Vorläufer der Förderinitiative "KMUinnovativ: Biotechnologie" darauf ab, innovative und anspruchsvolle Forschungsvorhaben von kleinen und mittleren...